Introduction
Esolina LS Capsule by Astemax Biotech combines esomeprazole gastro-resistant pellets with levosulpiride sustained-release formula, offering powerful dual-action relief from GERD and dyspepsia symptoms. This enteric-coated formulation protects active ingredients from stomach acid, ensuring optimal intestinal release for enhanced efficacy and minimal side effects.
Capsule Composition
Esolina LS contains esomeprazole 40 mg to potently suppress acid production and levosulpiride 75 mg SR to improve gastric motility and sphincter tone. The gastro-resistant coating on esomeprazole pellets prevents degradation, while levosulpiride provides steady prokinetic effects over 24 hours. Designed for once-daily convenience in managing acid reflux disorders.
Primary Benefits
-
Effectively controls heartburn, acidity, peptic ulcers, and functional dyspepsia by reducing acid and enhancing digestion.
-
Prevents acid backflow into the esophagus while alleviating nausea, bloating, and regurgitation.
-
Supports faster symptom relief and ulcer healing with superior bioavailability.
Manufacturing Quality
Produced in Astemax Biotech’s WHO-GMP certified facilities, Esolina LS meets rigorous global standards for purity, stability, and consistency. Ethical marketing highlights evidence-based outcomes to build physician confidence.
Dual Mechanism
Esomeprazole irreversibly blocks proton pumps for up to 95% acid reduction, complemented by levosulpiride’s selective D2 receptor antagonism that boosts peristalsis. The enteric-coated design maximizes absorption in the intestine for prolonged, efficient therapy.
Usage Recommendations
Take one capsule daily before meals, swallowed whole with water. Physician guidance required for extended use, pregnancy, or hepatic impairment. Store below 30°C away from moisture
